Epigenetic Modulation of IL‐7 and IL‐10: Toward Personalized Immune Therapies in Viral Epidemics
Journal of Immunology Research · 2026
DOI: 10.1155/jimr/9467657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Zerrin Yulugkural und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Trakya University, Edirne, Türkiye, trakya.edu.tr. Hauptthemen laut MEDLINE: Interleukin-7, Interleukin-10, Epigenesis, Genetic, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Host immune responses, including cytokine production, shape the severity of viral epidemics. Epigenetic mechanisms such as DNA methylation regulate cytokine gene expression and may contribute to immune dysregulation in severe disease.
Methods
This study analyzed interleukin‐7 (IL‐7), IL‐8, and IL‐10 promoter methylation in 145 COVID‐19 patients (91 wards, 54 intensive care units (ICUs)), excluding 12 patients receiving epigenetically active drugs. Peripheral blood DNA underwent bisulfite conversion, followed by PCR and gel electrophoresis. Gene‐specific methylation levels were quantified using beta values.
Results
IL‐7 was significantly hypermethylated overall (β = 0.835, p < 0.001), especially in ICU patients (β = 0.863, p = 0.001), independent of age, mortality, and malignancy. An interaction between age and ICU status indicated group‐specific effects. IL‐10 showed significant hypomethylation (β = 0.243, p < 0.001), while IL‐8 methylation did not differ significantly ( p = 0.373). ICU patients had higher mortality (26% vs 5.5%, p < 0.001).
Conclusion
IL‐7 hypermethylation may impair T‐cell–mediated immunity in severe cases, while IL‐10 hypomethylation may reflect enhanced immunosuppression. These findings suggest a role for epigenetic cytokine regulation in disease progression and may guide future immunomodulatory strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Trakya University, Edirne, Türkiye, trakya.edu.tr.
- Department of Biophysics, Trakya University, Edirne, Türkiye, trakya.edu.tr.
- Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, fau.eu.
- Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, fau.eu.
ORCID-Profile: Zerrin Yulugkural, Mustafa Yildiz, Ertugrul Topcu, Habibe Tülin Elmaslar Mert, Alp Temiz
Zitieren
APA
Yulugkural, Z., Yildiz, M., Topcu, E., Elmaslar Mert, H. T., & Temiz, A. (2026). Epigenetic Modulation of IL‐7 and IL‐10: Toward Personalized Immune Therapies in Viral Epidemics. Journal of Immunology Research. https://doi.org/10.1155/jimr/9467657
Vancouver
Yulugkural Z, Yildiz M, Topcu E, Elmaslar Mert HT, Temiz A. Epigenetic Modulation of IL‐7 and IL‐10: Toward Personalized Immune Therapies in Viral Epidemics. Journal of Immunology Research. 2026. doi:10.1155/jimr/9467657
BibTeX
@article{Yulugkural2026,
author = {Yulugkural, Zerrin and Yildiz, Mustafa and Topcu, Ertugrul and Elmaslar Mert, Habibe Tülin and Temiz, Alp},
title = {Epigenetic Modulation of IL‐7 and IL‐10: Toward Personalized Immune Therapies in Viral Epidemics},
journal = {Journal of Immunology Research},
year = {2026},
doi = {10.1155/jimr/9467657}
}
EUVIMED